Armata Pharmaceuticals (ARMP) Operating Income (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Operating Income of -$8.8 million for Q1 2026, down 7.25% on a YoY basis from -$9.5 million in Q1 2025, and up 36.45% sequentially from -$13.8 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Operating Income (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Operating Income data on file, last reported at -$8.8 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 7.25% year-over-year to -$8.8 million; the trailing twelve-month figure through Mar 2026 stood at -$37.2 million (up 7.85% YoY), and the FY2025 full-year result was -$36.6 million, up 13.67% from the prior year.
- Operating Income improved to -$8.8 million in Q1 2026, from -$13.8 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$6.8 million in Q2 2025 to a low of -$13.8 million in Q4 2025.
- A 5-year average of -$9.7 million and a median of -$9.6 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income sank 70.77% in 2022 and soared 42.55% in 2025, its largest moves.
- Tracing ARMP's Operating Income over 5 years: stood at -$10.3 million in 2022, then increased by 7.25% to -$9.6 million in 2023, then fell by 10.02% to -$10.5 million in 2024, then sank by 31.16% to -$13.8 million in 2025, then soared by 36.45% to -$8.8 million in 2026.
- Business Quant data shows ARMP's Operating Income at -$8.8 million in Q1 2026, -$13.8 million in Q4 2025, and -$7.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | -8.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.79 Mn |
| Dec 31, 2025 | -13.82 Mn |
| Sep 30, 2025 | -7.78 Mn |
| Jun 30, 2025 | -6.84 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -10.54 Mn |
| Sep 30, 2024 | -9.76 Mn |
| Jun 30, 2024 | -11.91 Mn |
| Mar 31, 2024 | -10.23 Mn |
| Dec 31, 2023 | -9.58 Mn |
| Sep 30, 2023 | -10.34 Mn |
| Jun 30, 2023 | -9.63 Mn |
| Mar 31, 2023 | -11.35 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -9.22 Mn |
| Mar 31, 2022 | -8.78 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | -6.14 Mn |
| Jun 30, 2021 | -6.20 Mn |